BDBM13886 1-[(3-carbamimidoylphenyl)methyl]-N-{[4-(dimethylamino)phenyl]methyl}-4-methyl-1H-indole-2-carboxamide; 2,2,2-trifluoroacetic acid::3-amidinobenzylindole carboxamide 71
SMILES: CN(C)c1ccc(CNC(=O)c2cc3c(C)cccc3n2Cc2cccc(c2)C(N)=N)cc1
InChI Key: InChIKey=PRIRHEBPAJTNLS-UHFFFAOYSA-N
Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Coagulation factor X (Homo sapiens (Human)) | BDBM13886 (1-[(3-carbamimidoylphenyl)methyl]-N-{[4-(dimethyla...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | Article PubMed | 1.31E+3 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Aventis Pharma Deutschland GmbH | Assay Description The inhibitory effect of test compound for human fXa was determined by using the chromogenic substrates S-2765. The hydrolysis rates of chromogenic s... | J Med Chem 45: 2749-69 (2002) Article DOI: 10.1021/jm0111346 BindingDB Entry DOI: 10.7270/Q27H1GTW | |||||||||||
More data for this Ligand-Target Pair |